Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subarachnoid vs Femoropopliteal Block for Limb Perfusion in PAD
NCT06702202Completed
- Sponsor
- Universitas Indonesia
- Start
- Jan 2024
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine and lidocaine in Peripheral Arterial Disease (PAD) (2 arms), sponsored by Universitas Indonesia. Primary endpoint: Tissue Oxygen Saturation at 30 months. Started Jan 2024; status: completed.
02
Drugs
bupivacainelidocaine
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT06702202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06702202.